Summary:
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.
Criteria:- Ability and willingness to provide written informed consent.
- Sufficiently fluent in English to participate in the trial.
- Male and female patients aged 18-70 years (inclusive).
Qualified Participants May Receive:
Monetary compensation for participating.